Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5200
-0.0050 (-0.95%)
Oct 27, 2026, 4:10 PM AEDT
Aroa Biosurgery Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aroa Biosurgery stock has a consensus rating of "Strong Buy" and an average price target of $1.07. The average 1-year stock price forecast is 105.77% higher than the current stock price, while the lowest is $0.79 (+51.92%) and the highest is $1.35 (+159.62%).
Price Target: $1.07 (+105.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aroa Biosurgery stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $1.09 | Buy | Maintains | $1.09 | +109.62% | Oct 7, 2026 |
| Morgans | Morgans | Buy Maintains $0.79 | Buy | Maintains | $0.79 | +51.92% | Sep 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.16 → $1.35 | Buy | Maintains | $1.16 → $1.35 | +159.62% | May 3, 2026 |
Financial Forecast
Revenue This Year
120.56M
from 103.85M
Increased by 16.09%
Revenue Next Year
138.32M
from 120.56M
Increased by 14.73%
EPS This Year
0.02
from 0.02
Decreased by -6.67%
EPS Next Year
0.04
from 0.02
Increased by 129.74%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.